|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/86 | (2006.01) |
| A61P 3/00 | (2018.01) | ||
| A61K 48/00 | (2006.01) | ||
| C12N2750/14143 | (2013.01) | ||
| A61K 38/47 | (2006.01) | ||
| C12N 15/86 | (2013.01) | ||
| A61P 3/00 | (2006.01) |
| (11) | Number of the document | 3252161 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17168189.3 |
| Date of filing the European patent application | 2008-06-02 | |
| (97) | Date of publication of the European application | 2017-12-06 |
| (45) | Date of publication and mention of the grant of the patent | 2021-11-17 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 924947 P | 2007-06-06 | US |
| (72) |
DODGE, James , US
CHENG, Seng , US
|
| (73) |
Genzyme Corporation ,
50 Binney Street, Cambridge, MA 02142,
US
|
| (54) | GENE THERAPY FOR LYSOSOMAL STORAGE DISEASES |
| GENE THERAPY FOR LYSOSOMAL STORAGE DISEASES |